Transcat Inc (TRNS)

Nov 4, 2026

Shares of Transcat (NASDAQ: TRNS) surged by 18.9% after the company reported strong third-quarter 2026 financial results, with total revenue increasing by 18% to $97.1 million and service revenue rising by 23%. The company also exceeded Wall Street's adjusted earnings estimates, delivering $0.64 per share compared to the consensus of $0.45 per share. This positive report has significantly impacted the market's perception of the business, pushing the stock to a new 52-week high.

Nov 4, 2026

Transcat (TRNS) shares reached a record high after the company reported better-than-expected quarterly earnings and improved its annual growth outlook. The provider of equipment calibration services and testing instruments saw an 18% increase in revenue to $97.1 million. The company expects continued organic service revenue growth and expanding service gross margins due to increased demand, market-share gains, and operational improvements.

Nov 3, 2026

Transcat Inc. reported an 18% increase in consolidated revenue to $97.1 million for Q2 2027, driven by strong growth in both service (up 23%) and distribution (up 10%) segments. The company saw a 31% rise in service gross profit, with margins expanding to 34.4%, and adjusted EBITDA increased 23%. Transcat raised its full-year service organic revenue growth outlook to low double digits, fueled by strategic acquisitions like Southeastern Biomedical Associates and ongoing operational improvements.